Immix Biopharma up 1.37% after-hour due to change in independent accounting firm to Crowe LLP.

Immix Biopharma, Inc. experienced a 1.37% increase in after-hours trading, following the announcement of a change in its independent registered public accounting firm. On July 17, 2024, KMJ Corbin & Company LLP was replaced by Crowe LLP as the Company's new independent auditor, as reported in the Form 8-K Item 4.01 Changes in Registrant's Certifying Accountant. This change in professional services may have influenced investors' expectations, contributing to the positive after-hours price movement.